Clinic
Maria Medical Group, LLC
Maria Medical Group, LLC was paid $1.72M by Medicaid between Jan 2018 and Nov 2024, across 30 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoMARIA MEDICAL GROUP, LLC
WICHITA, KS 67226
WICHITA, KS 67226
33aNPI1053740092assigned 11/08/2013
33bProvider typeUrgent Care Clinic/Center
28Total paid$1.72M
24GClaims48,113
24DCodes billed30
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Kansas
Rank by total paid#3 of 22
Median peer was paid$162K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,063 | $116K | |
| 2019 | 4,214 | $159K | |
| 2020 | 3,947 | $124K | |
| 2021 | 7,715 | $263K | |
| 2022 | 12,276 | $455K | |
| 2023 | 7,930 | $302K | |
| 2024incomplete | 8,968 | $300K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 12,155 | 11,156 | $583K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 25% | 5,215 | 4,977 | $434K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 10% | 5,662 | 5,413 | $173K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.7% | 4,623 | 4,322 | $149K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.6% | 2,450 | 2,388 | $148K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.8% | 5,374 | 2,627 | $65K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.3% | 3,447 | 3,112 | $39K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.1% | 439 | 427 | $37K |
| 87634 | 2.0% | 536 | 530 | $35K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 3,018 | 2,943 | $26K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 96 | 95 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 199 | 194 | $8K |
18 more codes
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,956 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 234 | $2K |
| 87807 | <1% | 103 | $1K | |
| 81003 | <1% | 719 | $918.43 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 16 | $455.94 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $453.46 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $453.46 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $447.61 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 17 | $212.52 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 189 | $135.06 |
| 81025 | <1% | 14 | $89.16 | |
| 94760 | <1% | 214 | $73.30 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 29 | $72.30 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 13 | $61.17 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12 | $53.17 |
| 36415 | Collection of venous blood by venipuncture | <1% | 85 | $1.08 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 46 | $0.00 |
| 99000 | 0% | 1,213 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMANSOOR, SAMRAH (MEDICAL DIRECTOR)